Related Experiment Video
Updated: Jul 29, 2026

Electrophysiological Measurements and Analysis of Nociception in Human Infants
Published on: December 20, 2011
Triculata A, a novel compound from Tricyrtis maculata (D. Don) J. F. Macbr. with biological properties
Li Ren1, Yun-Ze Wang1, Wei Zhang1
1Shaanxi Collaborative Innovation Center of Chinese Medicine Resources Industrialization, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang, P.R. China.
Abstract:
A novel compound, triculata A (1), and seven known compounds were obtained from the Tricyrtis maculata (D. Don) J. F. Macbr.. The structure of the new compound was determined by extensive spectroscopic methods, and its absolute configuration was assigned by single-crystal X-ray diffraction analysis. Compound 1 features a rare naphtho[b,c]pyran carbon skeleton that was found in nature for the first time. Compounds 2-4, 6 and 7 showed potential vasodilatory effects with EC50 values ranging from 7.3 to 111.3 μM. Compounds 1, 3-5 and 7 possessed remarkable antioxidant capacity evaluated by DPPH and ABTS assays.
Related Concept Videos
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic Antagonists: Pharmacokinetics

